Itaconix PLC Commencement of Trading on US OTCQB Market (2893X)
18 Dicembre 2019 - 09:00AM
UK Regulatory
TIDMITX
RNS Number : 2893X
Itaconix PLC
18 December 2019
18 December 2019
Itaconix plc ("Itaconix" or the "Company")
Itaconix Commences Trading on the US OTCQB Market
Itaconix (LSE: ITX) (OTCQB: ITXXF), a leading innovator in
sustainable specialty polymers, is pleased to announce that the
Company's shares will cross-trade publicly on the US OTCQB Market
under the symbol ITXXF effective at the open of the US market on
December 18, 2019.
Trading on the US OTC market will have no impact on the existing
listing of Itaconix ordinary shares on the London Stock Exchange
and no new ordinary shares were issued as part of the cross-trade.
The Company will continue to rely on the announcements and
disclosures it makes to the London Stock Exchange and has no
Sarbanes-Oxley or SEC reporting requirements.
The cross-trade is provided through OTC Markets Group Inc.,
located in New York, N.Y., which operates the world's largest
electronic interdealer quotation system for US broker dealers and
offers multiple media channels to increase the visibility of
OTC-listed companies. Independent studies show that trading on the
OTC by an international company offers a positive effect on the
liquidity of its shares.
John R. Shaw, Chief Executive Officer, stated: "I believe access
to trading our shares in the US will benefit all of our
shareholders. Our novel sustainable polymers have generated strong
interest and steady support from US-based investors. Today's move
onto the OTC Market facilitates investment from the United States
by simplifying the trading process for potential US investors,
enabling them to trade in our shares in US dollars during US
trading hours."
Ends
For further information please contact:
Itaconix +1 (603) 775 4400
John R. Shaw / Laura Denner
N+1 Singer +44 (0) 207 496 3000
Richard Lindley / James Moat (Corporate
Finance)
Mia Gardner (Corporate Broking)
About Itaconix
Itaconix plc (LSE: ITX) is a leading innovator in bio-based
functional ingredients for improving the safety and performance of
homecare, personal care, and industrial products. Its proprietary
polymer technology generates a growing range of new ingredients
with unique functionality that meet consumer demands for value and
sustainability.
www.itaconix.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCLIFVDFILTLIA
(END) Dow Jones Newswires
December 18, 2019 03:00 ET (08:00 GMT)
Grafico Azioni Itaconix (LSE:ITX)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Itaconix (LSE:ITX)
Storico
Da Mar 2023 a Mar 2024